Bart E. Burington
Impact in
- Hematology top 0.5%
- Multiple Myeloma Research and Treatments
-
- Intensive Care Unit Cognitive Disorders
Papers in
- Hematology 10
- Multiple Myeloma Research and Treatments 9
- Genetics 5
- Myeloproliferative Neoplasms: Diagnosis and Treatment 5
- Co-authors
- Jesse R. Fann (4 shared papers)Wayne J. Katon (4 shared papers)John J. Crowley (8 shared papers)John D. Shaughnessy (7 shared papers)Bart Barlogie (7 shared papers)Fenghuang Zhan (6 shared papers)Ichiro Hanamura (5 shared papers)Jeffrey R. Sawyer (3 shared papers)
- Journals
- Blood (13 papers)Clinical Cancer Research (2 papers)Cancer (2 papers)BMC Cancer (1 paper)Science Translational Medicine (1 paper)
- Partner nations
- United StatesGermanySwitzerland
In The Last Decade
Bart E. Burington
28 papers receiving 3.2k citations
Bart E. Burington's Hit Papers
Peers
Comparison fields: 5 of 81
- Hematology 1.9k
- Critical Care and Intensive Care Medicine 99
- Genetics 127
- Epidemiology 358
- Physiology 180
Countries citing papers authored by Bart E. Burington
This map shows the geographic impact of Bart E. Burington's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bart E. Burington with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bart E. Burington more than expected).
Fields of papers citing papers by Bart E. Burington
This network shows the impact of papers produced by Bart E. Burington. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bart E. Burington. The network helps show where Bart E. Burington may publish in the future.
Co-authors
The 25 scholars most cited alongside Bart E. Burington, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 29 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | The molecular classification of multiple myeloma Hit paper breakdown → | 2006 | 928 |
| 2 | A validated gene expression model of high-risk multiple myeloma is defined by deregulated expression of genes mapping to chromosome 1 Hit paper breakdown → | 2006 | 764 |
| 3 | 2006 | 401 | |
| 4 | 2004 | 319 | |
| 5 | 2015 | 172 | |
| 6 | 2014 | 151 | |
| 7 | 2004 | 92 | |
| 8 | 2004 | 84 | |
| 9 | 2002 | 83 | |
| 10 | 2005 | 75 | |
| 11 | 2023 | 46 | |
| 12 | 2023 | 45 | |
| 13 | 2008 | 37 | |
| 14 | 2011 | 34 | |
| 15 | 2003 | 27 | |
| 16 | 2012 | 17 | |
| 17 | 2019 | 14 | |
| 18 | 2009 | 11 | |
| 19 | 2020 | 9 | |
| 20 | 2005 | 4 |
About Bart E. Burington
Bart E. Burington is a scholar working on Hematology, Genetics, Pathology and Forensic Medicine, Critical Care and Intensive Care Medicine and Rheumatology, having authored 29 papers that have together received 3.3k indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (9 papers), Lymphoma Diagnosis and Treatment (5 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (5 papers), Traumatic Brain Injury Research (2 papers), Intensive Care Unit Cognitive Disorders (2 papers), Lung Cancer Treatments and Mutations (1 paper), Telomeres, Telomerase, and Senescence (1 paper) and Gene expression and cancer classification (1 paper). The work is most often cited by research in Hematology (1.9k citations), Critical Care and Intensive Care Medicine (99 citations), Genetics (127 citations), Epidemiology (358 citations) and Physiology (180 citations). Bart E. Burington has collaborated with scholars based in United States, Germany and Switzerland. Frequent co-authors include Jesse R. Fann, Wayne J. Katon, John J. Crowley, John D. Shaughnessy, Bart Barlogie, Fenghuang Zhan, Ichiro Hanamura, Jeffrey R. Sawyer, Guido J. K. Tricot and Maurizio Zangari. Their work appears in journals such as Blood, Clinical Cancer Research, Cancer, BMC Cancer and Science Translational Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.